Right Side News
The Government Accountability Office has just released a report detailing the massive opportunities for fraudulently getting tax credits in Obamacare’s health insurance exchanges. Obamacare sends billions of taxpayers’ dollars to health insurers which operate in these exchanges – $37 billion last year alone. These tax credits are used to discount premiums for plans offered in […]
AHIP chief Marilyn Tavenner blasts drug plans as Hillary Clinton proposal targets price hikes[/caption] The health insurance industry is undergoing a crisis of consensus on how to respond to the failure of Obamacare. That is the only way to interpret the departure of another large, national carrier, Aetna, from America’s Health Insurance Plans (AHIP). This […]
Devon Herrick | NCPA The House is voting on a reconciliation bill that would repeal much of Obamacare. It’s expected to pass easily – and be vetoed by President Obama. Before we discuss what should replace Obamacare it would be a valuable exercise to revisit what needs to be repealed. The employer mandate has to […]
Devon Herrick | NCPA The U.S. health care system is an unsustainable mess. Medical spending is rising at twice the rate of income growth. Medical prices are rising at three times the rate of consumer inflation. National health expenditures are approaching one-fifth of the economy. Currently the government funds about half of health care. In […]
John R. Graham | NCPA Prostate Specific Antigen (PSA) tests are back in the news, as they are one entry point for the government to start micromanaging how it pays doctors in Medicare. To set the stage: Currently, Medicare pays for an annual PSA test for men 50 and older as “preventive care.” However, Obamacare […]
No good words were used to describe last week’s Employment Situation Summary: “Every aspect of the September jobs report was disappointing,” wrote Michelle Girard, chief U.S. economist at RBS (quoted in Forbes). This is largely a repeat of the August jobs report, although those and previous months’ figures were also revised downwards. One quarter of […]
John R. Graham | NCPA Last week’s third estimate of Gross Domestic Product for the second quarter confirms that growth in health spending might be moderating somewhat from its initial Obamacare fueled rush. Unfortunately, it is not a clear break in the trend of health spending consuming an increasing share of our national income. Current GDP grew […]
Danny O’brien | EFF The maintainer of GoAgent, one of China’s more popular censorship circumvention tools emptied out the project’s main source code repositories on Tuesday. Phus Lu, the developer, renamed the repository’s description to “Everything that has a beginning has an end”. Phus Lu’s Twitter account’s historywas also deleted, except for a single tweet […]
The U.S. Court of Appeals for the D.C. Circuit’s opinion today in Klayman v. Obama is highly disappointing and, worse, based on a mistaken concern about the underlying facts. The court said that since the plaintiffs’ phone service was provided by one subsidiary of Verizon—Verizon Wireless—rather than another—Verizon Business—they couldn’t prove that they had standing to sue. The […]
By Lawrence N. Pivnick MD JD Something is rotten with the state of medicine today. Well, more than one thing actually, but today’s complaint concerns the fact that your doctor has been conscripted by the federal government to spy on your gun closet. This has occurred despite the fact that as Obamacare moved its way […]
The Fraser Institute has released a study estimating the costs of Canada’s government monopoly, a.k.a. single-payer health system. A typical Canadian family of four will pay $11,735 for public health care insurance in 2015. The study also tracks the cost of health care insurance over time: Between 2005 and 2015, the cost of health care for […]
John R. Graham | NCPA Judges are chipping away at government censorship of communications about prescription drugs. The Food and Drug Administration exerts great power over a medicine’s label, which describes the medicine’s therapeutic claims. Drug makers and the FDA sometimes spend years negotiating a label. The FDA regulates both safety and “efficacy.” So, a […]